CSIMarket
 


Cryoport inc   (CYRX)
Other Ticker:  
 
 

CYRX's Operating Income Growth by Quarter and Year

Cryoport Inc 's Operating Income results by quarter and year




CYRX Operating Income (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December -69.87 -11.04 -8.36 -10.73
III Quarter September -16.91 -7.80 -4.58 -5.85
II Quarter June -18.33 -5.25 -3.75 -3.59
I Quarter March -10.05 -7.82 -1.14 -0.88
FY   -115.16 -31.91 -17.83 -21.05



CYRX Operating Income fourth quarter 2023 Y/Y Growth Comment
Cryoport inc in the fourth quarter 2023 recorded Operating Loss of $ -69.87 millions.

According to the results reported in the fourth quarter 2023, Cryoport Inc achieved the best Operating Income growth in Major Pharmaceutical Preparations industry. While Cryoport Inc ' s Operating Income no change of % ranks overall at the positon no. in the fourth quarter 2023.

Explain Operating Income growth


CYRX Operating Income ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Cryoport Inc 's fourth quarter 2023 Operating Income $ -69.87 millions CYRX's Income Statement
Cryoport Inc 's fourth quarter 2022 Operating Income $ -11.04 millions Quarterly CYRX's Income Statement
New: More CYRX's historic Operating Income Growth >>


CYRX Operating Income (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Operating Income fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Operating Income fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Operating Income by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Cryoport Inc 's Q/Q Operating Income Growth


Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


CYRX's IV. Quarter Q/Q Operating Income Comment
Current results of -69.87 millions by Cryoport inc look even less good if you take a look at -16.91 millions a quarter before.

Within Major Pharmaceutical Preparations industry Cryoport inc achieved highest sequential Operating Income growth. While Cryoport Inc 's Operating Income growth quarter on quarter, overall rank is .


Operating Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


CYRX's IV. Quarter Q/Q Operating Income Comment
Current accomplishment of -69.87 millions by Cryoport inc appear even more unfavourable compare to the -16.91 millions Operating Loss in the previous quarter.

Within Major Pharmaceutical Preparations industry Cryoport inc achieved highest sequential Operating Income growth. While Cryoport Inc 's Operating Income growth quarter on quarter, overall rank is .


Cryoport Inc 's 12 Months Operating Income Growth Year on Year


Operating Income TTM Growth

12 Months Ending
(Dec 31 2023)
12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
Cumulative Operating Income 12 Months Ending $ -115.16 $ -56.32 $ -47.22 $ -34.13 $ -31.90
Y / Y Operating Income Growth (TTM) - - - - -
Year on Year Operating Income Growth Overall Ranking # # # # #
Seqeuential Operating Income Change (TTM) - - - - -
Seq. Operating Income Growth (TTM) Overall Ranking # # # # #




Cumulative Operating Income growth Comment
Cryoport Inc ' has realized cumulative trailing twelve months Operating Loss of $ -115 millions in the Dec 31 2023 period.
The business is detiriorating as the cumulative Operating Loss is inflating from $ -56.32 millions in TTM ending quarter Sep 30 2023 and $ -29.232 millions for the twelve months ending in the quarter Dec 31 2022.

Cryoport inc achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Operating Income growth Comment
Cryoport Inc ' has realized cumulative trailing twelve months Operating Loss of $ -115 millions in the Dec 31 2023 period.
The situation is getting worse as the cumulative Operating Loss is becoming larger from $ -56.32 millions in the twelve months ending a quarter before and $ -29.232 millions for the twelve months ending in the quarter Dec 31 2022.

Cryoport inc achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Operating Income Growth
Major Pharmaceutical Preparations Industry Operating Income Growth Trends and Statistics
Healthcare Sector Operating Income Growth Statistics
Operating Income Growth Trends for overall market
CYRX's Operating Income Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Operating Income Growth
Lowest Ranking Operating Income Growth
Operating Income Growth for CYRX's Competitors
Operating Income Growth for Cryoport Inc 's Suppliers
Operating Income Growth for CYRX's Customers

You may also want to know
CYRX's Annual Growth Rates CYRX's Profitability Ratios CYRX's Asset Turnover Ratio CYRX's Dividend Growth
CYRX's Roe CYRX's Valuation Ratios CYRX's Financial Strength Ratios CYRX's Dividend Payout Ratio
CYRX's Roa CYRX's Inventory Turnover Ratio CYRX's Growth Rates CYRX's Dividend Comparisons



Companies with similar Operating Income no change for the quarter ending Dec 31 2023 within Healthcare SectorY/Y Change %Operating Income for the quarter ending Dec 31 2023
Penumbra Inc 624.79%$ 624.788 millions
Collegium Pharmaceutical Inc 424.69%$ 424.692 millions
Insulet Corporation352.77%$ 352.766 millions
Progyny Inc 317.42%$ 317.423 millions
Ani Pharmaceuticals Inc269.56%$ 269.560 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com